 | • レポートコード：MRC2102QY11994 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の放射性医薬品市場について種類別（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他）、用途別（腫瘍学、心臓病学、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・放射性医薬品市場の概要 ・世界の主要地域別放射性医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の放射性医薬品市場規模2015-2026：種類別（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他） ・世界の放射性医薬品市場規模2015-2026：用途別（腫瘍学、心臓病学、その他） ・放射性医薬品の米国市場規模2015-2020 ・放射性医薬品のヨーロッパ市場規模2015-2020 ・放射性医薬品の中国市場規模2015-2020 ・放射性医薬品の日本市場規模2015-2020 ・放射性医薬品の東南アジア市場規模2015-2020 ・放射性医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・放射性医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・放射性医薬品の市場動向・機会・課題 ・調査の結論 |
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.
Market Analysis and Insights: Global Radiopharmaceutical Market
The global Radiopharmaceutical market size is projected to reach US$ 10520 million by 2026, from US$ 6410.1 million in 2020, at a CAGR of 8.6% during 2021-2026.
Global Radiopharmaceutical Scope and Market Size
The global Radiopharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Radiopharmaceutical market is segmented into
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Segment by Application, the Radiopharmaceutical market is segmented into
Oncology
Cardiology
Other
The Radiopharmaceutical market is analysed and market size information is provided by regions (countries). Segment by Application, the Radiopharmaceutical market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Radiopharmaceutical Market Share Analysis
Radiopharmaceutical market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Radiopharmaceutical business, the date to enter into the Radiopharmaceutical market, Radiopharmaceutical product introduction, recent developments, etc.
The major vendors covered:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
1 Radiopharmaceutical Market Overview
1.1 Radiopharmaceutical Product Scope
1.2 Radiopharmaceutical Segment by Type
1.2.1 Global Radiopharmaceutical Sales by Type (2020-2026)
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Radiopharmaceutical Segment by Application
1.3.1 Global Radiopharmaceutical Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Radiopharmaceutical Market Estimates and Forecasts (2015-2026)
1.4.1 Global Radiopharmaceutical Sales Growth Rate (2015-2026)
1.4.2 Global Radiopharmaceutical Revenue and Growth Rate (2015-2026)
1.4.3 Global Radiopharmaceutical Price Trends (2015-2026)
2 Radiopharmaceutical Estimate and Forecast by Region
2.1 Global Radiopharmaceutical Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Radiopharmaceutical Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Radiopharmaceutical Sales Market Share by Region (2015-2020)
2.2.2 Global Radiopharmaceutical Revenue Market Share by Region (2015-2020)
2.3 Global Radiopharmaceutical Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Radiopharmaceutical Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Radiopharmaceutical Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Radiopharmaceutical Estimates and Projections (2015-2026)
2.4.2 Europe Radiopharmaceutical Estimates and Projections (2015-2026)
2.4.3 China Radiopharmaceutical Estimates and Projections (2015-2026)
2.4.4 Japan Radiopharmaceutical Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Radiopharmaceutical Estimates and Projections (2015-2026)
2.4.6 India Radiopharmaceutical Estimates and Projections (2015-2026)
3 Global Radiopharmaceutical Competition Landscape by Players
3.1 Global Top Radiopharmaceutical Players by Sales (2015-2020)
3.2 Global Top Radiopharmaceutical Players by Revenue (2015-2020)
3.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2019)
3.4 Global Radiopharmaceutical Average Price by Company (2015-2020)
3.5 Manufacturers Radiopharmaceutical Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Radiopharmaceutical Players (Opinion Leaders)
4 Global Radiopharmaceutical Market Size by Type
4.1 Global Radiopharmaceutical Historic Market Review by Type (2015-2020)
4.1.1 Global Radiopharmaceutical Sales Market Share by Type (2015-2020)
4.1.2 Global Radiopharmaceutical Revenue Market Share by Type (2015-2020)
4.1.3 Global Radiopharmaceutical Price by Type (2015-2020)
4.2 Global Radiopharmaceutical Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Radiopharmaceutical Sales Forecast by Type (2021-2026)
4.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2021-2026)
4.2.3 Global Radiopharmaceutical Price Forecast by Type (2021-2026)
5 Global Radiopharmaceutical Market Size by Application
5.1 Global Radiopharmaceutical Historic Market Review by Application (2015-2020)
5.1.1 Global Radiopharmaceutical Sales Market Share by Application (2015-2020)
5.1.2 Global Radiopharmaceutical Revenue Market Share by Application (2015-2020)
5.1.3 Global Radiopharmaceutical Price by Application (2015-2020)
5.2 Global Radiopharmaceutical Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Radiopharmaceutical Sales Forecast by Application (2021-2026)
5.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2021-2026)
5.2.3 Global Radiopharmaceutical Price Forecast by Application (2021-2026)
6 United States Radiopharmaceutical Market Facts & Figures
6.1 United States Radiopharmaceutical Sales Market Share by Company (2015-2020)
6.2 United States Radiopharmaceutical Sales Market Share by Type (2015-2020)
6.3 United States Radiopharmaceutical Sales Market Share by Application (2015-2020)
7 Europe Radiopharmaceutical Market Facts & Figures
7.1 Europe Radiopharmaceutical Sales Market Share by Company (2015-2020)
7.2 Europe Radiopharmaceutical Sales Market Share by Type (2015-2020)
7.3 Europe Radiopharmaceutical Sales Market Share by Application (2015-2020)
8 China Radiopharmaceutical Market Facts & Figures
8.1 China Radiopharmaceutical Sales Market Share by Company (2015-2020)
8.2 China Radiopharmaceutical Sales Market Share by Type (2015-2020)
8.3 China Radiopharmaceutical Sales Market Share by Application (2015-2020)
9 Japan Radiopharmaceutical Market Facts & Figures
9.1 Japan Radiopharmaceutical Sales Market Share by Company (3015-3030)
9.2 Japan Radiopharmaceutical Sales Market Share by Type (2015-2020)
9.3 Japan Radiopharmaceutical Sales Market Share by Application (2015-2020)
10 Southeast Asia Radiopharmaceutical Market Facts & Figures
10.1 Southeast Asia Radiopharmaceutical Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Radiopharmaceutical Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Radiopharmaceutical Sales Market Share by Application (2015-2020)
11 India Radiopharmaceutical Market Facts & Figures
11.1 India Radiopharmaceutical Sales Market Share by Company (2015-2020)
11.2 India Radiopharmaceutical Sales Market Share by Type (2015-2020)
11.3 India Radiopharmaceutical Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Radiopharmaceutical Business
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Business Overview
12.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bracco Imaging Radiopharmaceutical Products Offered
12.1.5 Bracco Imaging Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Radiopharmaceutical Products Offered
12.2.5 Bayer Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mallinckrodt Radiopharmaceutical Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Nordion
12.4.1 Nordion Corporation Information
12.4.2 Nordion Business Overview
12.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Nordion Radiopharmaceutical Products Offered
12.4.5 Nordion Recent Development
12.5 Triad Isotopes
12.5.1 Triad Isotopes Corporation Information
12.5.2 Triad Isotopes Business Overview
12.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Triad Isotopes Radiopharmaceutical Products Offered
12.5.5 Triad Isotopes Recent Development
12.6 Lantheus
12.6.1 Lantheus Corporation Information
12.6.2 Lantheus Business Overview
12.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lantheus Radiopharmaceutical Products Offered
12.6.5 Lantheus Recent Development
12.7 IBA Group
12.7.1 IBA Group Corporation Information
12.7.2 IBA Group Business Overview
12.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 IBA Group Radiopharmaceutical Products Offered
12.7.5 IBA Group Recent Development
12.8 GE Healthcare
12.8.1 GE Healthcare Corporation Information
12.8.2 GE Healthcare Business Overview
12.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GE Healthcare Radiopharmaceutical Products Offered
12.8.5 GE Healthcare Recent Development
12.9 China Isotope & Radiation
12.9.1 China Isotope & Radiation Corporation Information
12.9.2 China Isotope & Radiation Business Overview
12.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 China Isotope & Radiation Radiopharmaceutical Products Offered
12.9.5 China Isotope & Radiation Recent Development
12.10 Jubilant Pharma
12.10.1 Jubilant Pharma Corporation Information
12.10.2 Jubilant Pharma Business Overview
12.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Jubilant Pharma Radiopharmaceutical Products Offered
12.10.5 Jubilant Pharma Recent Development
12.11 Eli Lilly
12.11.1 Eli Lilly Corporation Information
12.11.2 Eli Lilly Business Overview
12.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Eli Lilly Radiopharmaceutical Products Offered
12.11.5 Eli Lilly Recent Development
12.12 Advanced Accelerator Applications
12.12.1 Advanced Accelerator Applications Corporation Information
12.12.2 Advanced Accelerator Applications Business Overview
12.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Advanced Accelerator Applications Radiopharmaceutical Products Offered
12.12.5 Advanced Accelerator Applications Recent Development
12.13 SIEMENS
12.13.1 SIEMENS Corporation Information
12.13.2 SIEMENS Business Overview
12.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.13.4 SIEMENS Radiopharmaceutical Products Offered
12.13.5 SIEMENS Recent Development
12.14 Dongcheng
12.14.1 Dongcheng Corporation Information
12.14.2 Dongcheng Business Overview
12.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Dongcheng Radiopharmaceutical Products Offered
12.14.5 Dongcheng Recent Development
12.15 Navidea
12.15.1 Navidea Corporation Information
12.15.2 Navidea Business Overview
12.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Navidea Radiopharmaceutical Products Offered
12.15.5 Navidea Recent Development
13 Radiopharmaceutical Manufacturing Cost Analysis
13.1 Radiopharmaceutical Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Radiopharmaceutical
13.4 Radiopharmaceutical Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Radiopharmaceutical Distributors List
14.3 Radiopharmaceutical Customers
15 Market Dynamics
15.1 Radiopharmaceutical Market Trends
15.2 Radiopharmaceutical Opportunities and Drivers
15.3 Radiopharmaceutical Market Challenges
15.4 Radiopharmaceutical Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Radiopharmaceutical Sales (M Doses) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Radiopharmaceutical Sales (M Doses) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Radiopharmaceutical Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Radiopharmaceutical Sales (M Doses) by Region (2015-2020)
Table 5. Global Radiopharmaceutical Sales Market Share by Region (2015-2020)
Table 6. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Radiopharmaceutical Revenue Share by Region (2015-2020)
Table 8. Global Radiopharmaceutical Sales (M Doses) Forecast by Region (2021-2026)
Table 9. Global Radiopharmaceutical Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Radiopharmaceutical Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Radiopharmaceutical Revenue Share Forecast by Region (2021-2026)
Table 12. Global Radiopharmaceutical (M Doses) of Key Companies (2015-2020)
Table 13. Global Radiopharmaceutical Sales Share by Company (2015-2020)
Table 14. Global Radiopharmaceutical Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Radiopharmaceutical Revenue Share by Company (2015-2020)
Table 16. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2019)
Table 17. Global Radiopharmaceutical Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Radiopharmaceutical Manufacturing Sites and Area Served
Table 19. Manufacturers Radiopharmaceutical Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Radiopharmaceutical Players
Table 22. Global Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 23. Global Radiopharmaceutical Sales Share by Type (2015-2020)
Table 24. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Radiopharmaceutical Price (M Doses) by Type (2015-2020)
Table 26. Global Radiopharmaceutical Sales Share by Type (2021-2026)
Table 27. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Radiopharmaceutical Revenue Share by Type (2021-2026)
Table 29. Global Radiopharmaceutical Price (M Doses) by Type (2021-2026)
Table 30. Global Radiopharmaceutical Sales (M Doses) by Application (2015-2020)
Table 31. Global Radiopharmaceutical Sales Share by Application (2015-2020)
Table 32. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Radiopharmaceutical Price (M Doses) by Application (2015-2020)
Table 34. Global Radiopharmaceutical Sales (M Doses) by Application (2021-2026)
Table 35. Global Radiopharmaceutical Sales Share by Application (2021-2026)
Table 36. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Radiopharmaceutical Revenue Share by Application (2021-2026)
Table 38. Global Radiopharmaceutical Price (M Doses) by Application (2021-2026)
Table 39. United States Radiopharmaceutical Sales (M Doses) by Company (2015-2020)
Table 40. United States Radiopharmaceutical Sales Market Share by Company (2015-2020)
Table 41. United States Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 42. United States Radiopharmaceutical Sales Market Share by Type (2015-2020)
Table 43. United States Radiopharmaceutical Sales (M Doses) by Application (2015-2020)
Table 44. United States Radiopharmaceutical Sales Market Share by Application (2015-2020)
Table 45. Europe Radiopharmaceutical Sales (M Doses) by Company (2015-2020)
Table 46. Europe Radiopharmaceutical Sales Market Share by Company (2015-2020)
Table 47. Europe Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 48. Europe Radiopharmaceutical Sales Market Share by Type (2015-2020)
Table 49. Europe Radiopharmaceutical Sales (M Doses) by Application (2015-2020)
Table 50. Europe Radiopharmaceutical Sales Market Share by Type (2015-2020)
Table 51. China Radiopharmaceutical Sales (M Doses) by Company (2015-2020)
Table 52. China Radiopharmaceutical Sales Market Share by Company (2015-2020)
Table 53. China Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 54. China Radiopharmaceutical Sales Market Share by Type (2015-2020)
Table 55. China Radiopharmaceutical Sales (M Doses) by Application (2015-2020)
Table 56. China Radiopharmaceutical Sales Market Share by Application (2015-2020)
Table 57. Japan Radiopharmaceutical Sales (M Doses) by Company (2015-2020)
Table 58. Japan Radiopharmaceutical Sales Market Share by Company (2015-2020)
Table 59. Japan Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 60. Japan Radiopharmaceutical Sales Market Share by Type (2015-2020)
Table 61. Japan Radiopharmaceutical Sales (M Doses) by Application (2015-2020)
Table 62. Japan Radiopharmaceutical Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Radiopharmaceutical Sales (M Doses) by Company (2015-2020)
Table 64. Southeast Asia Radiopharmaceutical Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 66. Southeast Asia Radiopharmaceutical Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 68. Southeast Asia Radiopharmaceutical Sales Market Share by Application (2015-2020)
Table 69. India Radiopharmaceutical Sales (M Doses) by Company (2015-2020)
Table 70. India Radiopharmaceutical Sales Market Share by Company (2015-2020)
Table 71. India Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 72. India Radiopharmaceutical Sales Market Share by Type (2015-2020)
Table 73. India Radiopharmaceutical Sales (M Doses) by Application (2015-2020)
Table 74. India Radiopharmaceutical Sales Market Share by Application (2015-2020)
Table 75. Bracco Imaging Corporation Information
Table 76. Bracco Imaging Description and Business Overview
Table 77. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Bracco Imaging Radiopharmaceutical Product
Table 79. Bracco Imaging Recent Development
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Bayer Radiopharmaceutical Product
Table 84. Bayer Recent Development
Table 85. Mallinckrodt Corporation Information
Table 86. Mallinckrodt Description and Business Overview
Table 87. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Mallinckrodt Radiopharmaceutical Product
Table 89. Mallinckrodt Recent Development
Table 90. Nordion Corporation Information
Table 91. Nordion Description and Business Overview
Table 92. Nordion Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Nordion Radiopharmaceutical Product
Table 94. Nordion Recent Development
Table 95. Triad Isotopes Corporation Information
Table 96. Triad Isotopes Description and Business Overview
Table 97. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Triad Isotopes Radiopharmaceutical Product
Table 99. Triad Isotopes Recent Development
Table 100. Lantheus Corporation Information
Table 101. Lantheus Description and Business Overview
Table 102. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Lantheus Radiopharmaceutical Product
Table 104. Lantheus Recent Development
Table 105. IBA Group Corporation Information
Table 106. IBA Group Description and Business Overview
Table 107. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. IBA Group Radiopharmaceutical Product
Table 109. IBA Group Recent Development
Table 110. GE Healthcare Corporation Information
Table 111. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. GE Healthcare Description and Business Overview
Table 113. GE Healthcare Radiopharmaceutical Product
Table 114. GE Healthcare Recent Development
Table 115. China Isotope & Radiation Corporation Information
Table 116. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. China Isotope & Radiation Description and Business Overview
Table 118. China Isotope & Radiation Radiopharmaceutical Product
Table 119. China Isotope & Radiation Recent Development
Table 120. Jubilant Pharma Corporation Information
Table 121. Jubilant Pharma Description and Business Overview
Table 122. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Jubilant Pharma Radiopharmaceutical Product
Table 124. Jubilant Pharma Recent Development
Table 125. Eli Lilly Corporation Information
Table 126. Eli Lilly Description and Business Overview
Table 127. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Eli Lilly Radiopharmaceutical Product
Table 129. Eli Lilly Recent Development
Table 130. Advanced Accelerator Applications Corporation Information
Table 131. Advanced Accelerator Applications Description and Business Overview
Table 132. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Advanced Accelerator Applications Radiopharmaceutical Product
Table 134. Advanced Accelerator Applications Recent Development
Table 135. SIEMENS Corporation Information
Table 136. SIEMENS Description and Business Overview
Table 137. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. SIEMENS Radiopharmaceutical Product
Table 139. SIEMENS Recent Development
Table 140. Dongcheng Corporation Information
Table 141. Dongcheng Description and Business Overview
Table 142. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Dongcheng Radiopharmaceutical Product
Table 144. Dongcheng Recent Development
Table 145. Navidea Corporation Information
Table 146. Navidea Description and Business Overview
Table 147. Navidea Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Navidea Radiopharmaceutical Product
Table 149. Navidea Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Radiopharmaceutical Distributors List
Table 153. Radiopharmaceutical Customers List
Table 154. Radiopharmaceutical Market Key Trends
Table 155. Radiopharmaceutical Key Opportunities and Drivers
Table 156. Radiopharmaceutical Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Radiopharmaceutical Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Cardiology Examples
Figure 8. Other Examples
Figure 9. Global Radiopharmaceutical Sales (M Doses) Growth Rate (2015-2026)
Figure 10. Global Radiopharmaceutical Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Radiopharmaceutical Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global Radiopharmaceutical Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Radiopharmaceutical Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Radiopharmaceutical Sales (M Doses) Growth Rate (2015-2026)
Figure 16. Europe Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Radiopharmaceutical Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Radiopharmaceutical Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Radiopharmaceutical Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Radiopharmaceutical Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Radiopharmaceutical Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Radiopharmaceutical Players Market Share by Revenue in Radiopharmaceutical 2015 & 2019
Figure 27. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Radiopharmaceutical Revenue Share by Type (2015-2020)
Figure 29. Global Radiopharmaceutical Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Radiopharmaceutical Revenue Share by Application (2015-2020)
Figure 31. Global Radiopharmaceutical Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Radiopharmaceutical Sales Market Share by Type in 2019
Figure 33. United States Radiopharmaceutical Sales Market Share by Type in 2019
Figure 34. Europe Radiopharmaceutical Sales Market Share by Company in 2019
Figure 35. Europe Radiopharmaceutical Sales Market Share by Type in 2019
Figure 36. Europe Radiopharmaceutical Sales Market Share by Application in 2019
Figure 37. China Radiopharmaceutical Sales Market Share by Company in 2019
Figure 38. China Radiopharmaceutical Sales Market Share by Type in 2019
Figure 39. China Radiopharmaceutical Sales Market Share by Application in 2019
Figure 40. Japan Radiopharmaceutical Sales Market Share by Company in 2019
Figure 41. Japan Radiopharmaceutical Sales Market Share by Type in 2019
Figure 42. Japan Radiopharmaceutical Sales Market Share by Application in 2019
Figure 43. Southeast Asia Radiopharmaceutical Sales Market Share by Company in 2019
Figure 44. Southeast Asia Radiopharmaceutical Sales Market Share by Type in 2019
Figure 45. Southeast Asia Radiopharmaceutical Sales Market Share by Application in 2019
Figure 46. India Radiopharmaceutical Sales Market Share by Company in 2019
Figure 47. India Radiopharmaceutical Sales Market Share by Type in 2019
Figure 48. India Radiopharmaceutical Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Radiopharmaceutical
Figure 51. Manufacturing Process Analysis of Radiopharmaceutical
Figure 52. Radiopharmaceutical Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
酸化ルテチウムの世界市場レポート2020 Lutetium oxide, a white solid, is a cubic compound of lutetium sometimes used in the preparation of specialty glasses. It is also called lutecia. It is a lanthanide oxide, also known as a rare earth. At present, the global Lutetium Oxide market is dominated by Chinese enterprises. China is the world…- 心臓病電極の世界市場レポート2020 Electrocardiography is the process of recording the electrical activity of the heart over a period of time using electrodes placed on the skin. These electrodes detect the tiny electrical changes on the skin that arise from the heart muscle's electrophysiologic pattern of depolarizing and repolarizi…
- インターベンショナル心臓病学・末梢血管装置の世界市場レポート2020 Market Analysis and Insights: Global Interventional Cardiology and Peripheral Vascular Devices Market The global Interventional Cardiology and Peripheral Vascular Devices market size is projected to reach US$ 24270 million by 2026, from US$ 20180 million in 2020, at a CAGR of 3.1% during 2021-2026. …
- 改装心臓血管・心臓病学機器の世界市場レポート2020 Market Analysis and Insights: Global Refurbished Cardiovascular and Cardiology Equipment Market The global Refurbished Cardiovascular and Cardiology Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Refurbished …
- インターベンショナル心臓病学の世界市場レポート2020 Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound. The industry's leading manufacturers are …